Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017509 · ClinicalTrials.gov registry record
Immunoscore in Rectal Cancer
A clinical trial, sponsored by Providence Health & Services.
- Completed
- Registry status
- 3
- Enrollment target
NCT02017509: Completed study, sponsored by Providence Health & Services.
NCT02017509 is a clinical trial that has completed, run by Providence Health & Services. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02017509 has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is an observational study of tumor samples and MRI imaging in patients with colorectal cancers. A tumor sample, MRI scans, and treatment outcome data will be used for research purposes to see if it is possible to predict patients' response to treatment.
Primary Outcome
Quantitative immunohistochemical analysis will be performed on parameters of interest on both pre-treatment biopsy specimens as well as post-operative specimens. The pre-treatment sample will be used to establish the immunophenotype score. The primary analysis will evaluate the ability of immunophenotype score to correlate with pathologic response.
Interventions
- PROCEDURE Diagnostic Biopsy and Surgical Procedure
- PROCEDURE Intravoxel incoherent motion MRI (IVIM)
- PROCEDURE Dynamic Contrast Enhanced MRI (DCE-MRI)
- GENETIC RNA gene expression analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-01-24 |
| Est. Completion | 2018-07-17 |
What the finished NCT02017509 record still lists
NCT02017509 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Diagnostic Biopsy and Surgical Procedure is the first listed.
NCT02017509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02017509 about?
NCT02017509 is a clinical study titled "Immunoscore in Rectal Cancer". This is an observational study of tumor samples and MRI imaging in patients with colorectal cancers. A tumor sample, MRI scans, and treatment outcome data will be used for research purposes to see if it is possible to predict patients' response to treatment.
What is the current status of trial NCT02017509?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2014-01-24. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT02017509?
The interventions under investigation include: Diagnostic Biopsy and Surgical Procedure (PROCEDURE), Intravoxel incoherent motion MRI (IVIM) (PROCEDURE), Dynamic Contrast Enhanced MRI (DCE-MRI) (PROCEDURE), RNA gene expression analysis (GENETIC).
Who is sponsoring clinical trial NCT02017509?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI